Congress Calls Out Clinical Trials in PRC

Posted 8/24/24

House lawmakers are raising questions about US biopharmaceutical companies that are conducting clinical trials with China’s People’s Liberation Army and in the Xinjiang region where Beijing is accused of mistreating members of the Uyghur community.

Chinese biopharmaceutical companies, with their ability to harness China’s large population of patients to conduct time- and cost-efficient clinical trials play a vital role in the global pharmaceutical industry. The lawmakers want the Food and Drug Administration to provide information about these practices.

This item is available in full to subscribers.

Attention subscribers

To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.

If you are a current subscriber, and had an account on our previous site, you already have an account. If you have not yet logged into our new site, click here to reset your password.

Otherwise, click here to view your options for subscribing.

E-edition

September, 2024 Export Practitioner

View this issue

Browse other issues

Recent stories

BIS Issues GP 10 Guidance to Financial Institutions

The Commerce Department's Bureau of Industry and Security (BIS) published guidance for financial institutions containing best practice recommendations for complying with the Export Administration Regulations (EAR). The guidance focuses on General Prohibition 10 (GP 10), which prohibits financial institutions (and other persons) from financing or otherwise servicing any item subject to the EAR with knowledge that a violation of EAR has occurred, is about to occur, or is intended to occur.

DDTC Settles with Precision Castparts

Precision Castparts Corp. settled allegations that it violated the International Traffic in Arms Regulations (ITAR) in connection with unauthorized exports of technical data to foreign-person employees from Bhutan, Burundi, El Salvador, Honduras, Mexico, and Peru pertaining to tools (specifically, wax pattern and core dies) and wax patterns consumed in the subsequent production of casting blades used in gas turbine engines

UK launches new Trade Enforcement Body

From October, the Office of Trade Sanctions Implementation (OTSI) will be empowered to investigate breaches of trade sanctions and impose corresponding civil monetary penalties. We examine the powers OTSI will have, how it will interact with other UK sanctions authorities and what impact it may have.

OFAC May 2024 Reporting Rule Final

OFAC is amending the Reporting, Procedures and Penalties Regulations (RPPR). the May 2024 Interim Final Rule requiring reports witin 10 business days of when blocked property is unblocked or transferred, This final rule adds three exceptions to the reporting requirement for any blocked property that is unblocked or transferred.

DOJ, Microsoft Target Russian Hackers

The Justice Department announced the unsealing of a warrant authorizing the seizure of 41 internet domains used by Russian intelligence agents and their proxies to commit computer fraud and abuse in the United States. As an example of public-private operational collaboration the Department acted concurrently with a Microsoft civil action to restrain 66 internet domains used by the same actors

FCPA Enforcement Up Some, Still Down

After a particularly slow second quarter, FCPA enforcement activity picked up between July and September of 2024, with the DOJ initiating one new FCPA-related enforcement action, unsealing two previously filed actions, and issuing one declination letter, according to a tally from Stanford University's FCPA Clearinghouse. "Enforcement activity through Q3 of this year remained well below even the last three years of lower than average enforcement" the report notes